CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Idera Pharmaceuticals, Inc. Company Snapshot
Idera Pharmaceuticals, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Idera Pharmaceuticals with three other companies in this sector in the United States: Trovagene Inc (2015 sales of $312,812.00 of which 100% was Biological Product), Hemispherx Biopharma, Inc. ($133,000.00 of which 100% was Biomedical R & D), and Pluristem Therapeutics Incorporation. ($379,000.00 of which 100% was Stem Cells Expansion).

Sales Analysis. Sales increased substantially in 2015: During the year ended December of 2015, sales at Idera Pharmaceuticals were $249,000.00 . This is an increase of 241.1% versus 2014, when the company's sales were $73,000.00 .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Idera Pharmaceuticals, Inc.
  Stock Performance Chart for Idera Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/23/2016): 2.76
(Figures in U.S. Dollars)
1 Week 27.8%   13 Weeks 44.5%  
4 Weeks 86.5%   52 Weeks -22.3%  
 
Idera Pharmaceuticals, Inc. Key Data:
  Ticker: IDRA Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 249,000
(Year Ending Jan 2016).
Employees: 18
  Currency: U.S. Dollars Market Cap: 335,005,173
  Fiscal Yr Ends: December Shares Outstanding: 121,378,686
  Share Type: Common Closely Held Shares: 19,333,847
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.